オピオイド誘発性便秘（OIC）薬の世界市場レポート2020

• 英文タイトル：Global Opioid Induced Constipation (OIC) Drugs Sales Market Report 2020

• レポートコード：20QY06-01231 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥600,000 (USD4,000)	▷ お問い合わせ
Multi User	￥900,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,200,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社の当調査資料では、オピオイド誘発性便秘（OIC）薬のグローバル市場について種類別（ルビプロストン、メチルナルトレキソンブロミド、ナルデメジン、アルビモパン、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・オピオイド誘発性便秘（OIC）薬市場の概要 ・世界の主要地域別オピオイド誘発性便秘（OIC）薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のオピオイド誘発性便秘（OIC）薬市場規模2015-2026：種類別（ルビプロストン、メチルナルトレキソンブロミド、ナルデメジン、アルビモパン、その他） ・世界のオピオイド誘発性便秘（OIC）薬市場規模2015-2026：用途別（病院薬局、小売薬局、オンライン薬局） ・オピオイド誘発性便秘（OIC）薬の北米市場規模2015-2020 ・オピオイド誘発性便秘（OIC）薬のヨーロッパ市場規模2015-2020 ・オピオイド誘発性便秘（OIC）薬の中国市場規模2015-2020 ・オピオイド誘発性便秘（OIC）薬の日本市場規模2015-2020 ・オピオイド誘発性便秘（OIC）薬の東南アジア市場規模2015-2020 ・オピオイド誘発性便秘（OIC）薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Ironwood Pharmaceuticals Inc、Daiichi Sankyo Co Ltd、Pfizer、Progenics Pharmaceuticals Inc、Shionogi & Co., Ltd、Allergan Plc、Nektar Therapeutics、Purdue Pharma、S.L.A. Pharma AG、Mundipharma International Limited、Ono Pharmaceutical Co., Ltd、Takeda Pharmaceutical Company Limited、Theravance Biopharma Inc、Bausch Health、Cosmo Pharmaceuticals SA、Daewoong Pharmaceutical、C.B. Fleet Company、Sucampo Pharmaceuticals） ・オピオイド誘発性便秘（OIC）薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・オピオイド誘発性便秘（OIC）薬の市場動向・機会・課題 ・調査の結論

Market Analysis and Insights: Global Opioid Induced Constipation (OIC) Drugs Market
The global Opioid Induced Constipation (OIC) Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Opioid Induced Constipation (OIC) Drugs Scope and Market Size
The global Opioid Induced Constipation (OIC) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Induced Constipation (OIC) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Opioid Induced Constipation (OIC) Drugs market is segmented into
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other

Segment by Application, the Opioid Induced Constipation (OIC) Drugs market is segmented into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The Opioid Induced Constipation (OIC) Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Opioid Induced Constipation (OIC) Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Opioid Induced Constipation (OIC) Drugs Market Share Analysis
Opioid Induced Constipation (OIC) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Opioid Induced Constipation (OIC) Drugs business, the date to enter into the Opioid Induced Constipation (OIC) Drugs market, Opioid Induced Constipation (OIC) Drugs product introduction, recent developments, etc.
The major vendors covered:
Ironwood Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc
Shionogi & Co., Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co., Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc
Bausch Health
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals

レポート目次

---

Table of Contents

1 Opioid Induced Constipation (OIC) Drugs Market Overview
1.1 Opioid Induced Constipation (OIC) Drugs Product Scope
1.2 Opioid Induced Constipation (OIC) Drugs Segment by Type
1.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales by Type (2020-2026)
1.2.2 Lubiprostone
1.2.3 Methyl Naltrexone Bromide
1.2.4 Naldemedine
1.2.5 Alvimopan
1.2.6 Other
1.3 Opioid Induced Constipation (OIC) Drugs Segment by Application
1.3.1 Global Opioid Induced Constipation (OIC) Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Opioid Induced Constipation (OIC) Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Opioid Induced Constipation (OIC) Drugs Price Trends (2015-2026)

2 Opioid Induced Constipation (OIC) Drugs Estimate and Forecast by Region
2.1 Global Opioid Induced Constipation (OIC) Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Opioid Induced Constipation (OIC) Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Opioid Induced Constipation (OIC) Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Opioid Induced Constipation (OIC) Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Opioid Induced Constipation (OIC) Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Opioid Induced Constipation (OIC) Drugs Estimates and Projections (2015-2026)
2.4.3 China Opioid Induced Constipation (OIC) Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Opioid Induced Constipation (OIC) Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Opioid Induced Constipation (OIC) Drugs Estimates and Projections (2015-2026)
2.4.6 India Opioid Induced Constipation (OIC) Drugs Estimates and Projections (2015-2026)
3 Global Opioid Induced Constipation (OIC) Drugs Competition Landscape by Players
3.1 Global Top Opioid Induced Constipation (OIC) Drugs Players by Sales (2015-2020)
3.2 Global Top Opioid Induced Constipation (OIC) Drugs Players by Revenue (2015-2020)
3.3 Global Opioid Induced Constipation (OIC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Induced Constipation (OIC) Drugs as of 2019)
3.4 Global Opioid Induced Constipation (OIC) Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Opioid Induced Constipation (OIC) Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Opioid Induced Constipation (OIC) Drugs Players (Opinion Leaders)
4 Global Opioid Induced Constipation (OIC) Drugs Market Size by Type
4.1 Global Opioid Induced Constipation (OIC) Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Opioid Induced Constipation (OIC) Drugs Price by Type (2014-2020)
4.2 Global Opioid Induced Constipation (OIC) Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Opioid Induced Constipation (OIC) Drugs Price Forecast by Type (2021-2026)
5 Global Opioid Induced Constipation (OIC) Drugs Market Size by Application
5.1 Global Opioid Induced Constipation (OIC) Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Opioid Induced Constipation (OIC) Drugs Price by Application (2015-2020)
5.2 Global Opioid Induced Constipation (OIC) Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Opioid Induced Constipation (OIC) Drugs Price Forecast by Application (2021-2026)

3 North America Opioid Induced Constipation (OIC) Drugs Market Facts & Figures
3.2 North America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company (2015-2020)
3.3 North America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2015-2020)
3.4 North America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2015-2020)

4 Europe Opioid Induced Constipation (OIC) Drugs Market Facts & Figures
4.2 Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2015-2020)

5 China Opioid Induced Constipation (OIC) Drugs Market Facts & Figures
5.2 China Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company (2015-2020)
5.3 China Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2015-2020)
5.4 China Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2015-2020)

6 Japan Opioid Induced Constipation (OIC) Drugs Market Facts & Figures
6.2 Japan Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2015-2020)

7 Southeast Asia Opioid Induced Constipation (OIC) Drugs Market Facts & Figures
7.2 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2015-2020)

8 India Opioid Induced Constipation (OIC) Drugs Market Facts & Figures
8.2 India Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company (2015-2020)
8.3 India Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2015-2020)
8.4 India Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Opioid Induced Constipation (OIC) Drugs Business
12.1 Ironwood Pharmaceuticals Inc
12.1.1 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Corporation Information
12.1.2 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Business Overview and Total Revenue
12.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered
12.1.5 Ironwood Pharmaceuticals Inc Recent Development
12.2 Daiichi Sankyo Co Ltd
12.2.1 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Corporation Information
12.2.2 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Business Overview and Total Revenue
12.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Products Offered
12.2.5 Daiichi Sankyo Co Ltd Recent Development
12.3 Pfizer
12.3.1 Pfizer Opioid Induced Constipation (OIC) Drugs Corporation Information
12.3.2 Pfizer Opioid Induced Constipation (OIC) Drugs Business Overview and Total Revenue
12.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Opioid Induced Constipation (OIC) Drugs Products Offered
12.3.5 Pfizer Recent Development
12.4 Progenics Pharmaceuticals Inc
12.4.1 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Corporation Information
12.4.2 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Business Overview and Total Revenue
12.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Products Offered
12.4.5 Progenics Pharmaceuticals Inc Recent Development
12.5 Shionogi & Co., Ltd
12.5.1 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Corporation Information
12.5.2 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Business Overview and Total Revenue
12.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Products Offered
12.5.5 Shionogi & Co., Ltd Recent Development
12.6 Allergan Plc
12.6.1 Allergan Plc Opioid Induced Constipation (OIC) Drugs Corporation Information
12.6.2 Allergan Plc Opioid Induced Constipation (OIC) Drugs Business Overview and Total Revenue
12.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Allergan Plc Opioid Induced Constipation (OIC) Drugs Products Offered
12.6.5 Allergan Plc Recent Development
12.7 Nektar Therapeutics
12.7.1 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Corporation Information
12.7.2 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Business Overview and Total Revenue
12.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Products Offered
12.7.5 Nektar Therapeutics Recent Development
12.8 Purdue Pharma
12.8.1 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Corporation Information
12.8.2 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Business Overview and Total Revenue
12.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Products Offered
12.8.5 Purdue Pharma Recent Development
12.9 S.L.A. Pharma AG
12.9.1 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Corporation Information
12.9.2 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Business Overview and Total Revenue
12.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Products Offered
12.9.5 S.L.A. Pharma AG Recent Development
12.10 Mundipharma International Limited
12.10.1 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Corporation Information
12.10.2 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Business Overview and Total Revenue
12.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Products Offered
12.10.5 Mundipharma International Limited Recent Development
12.11 Ono Pharmaceutical Co., Ltd
12.11.1 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Corporation Information
12.11.2 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Business Overview and Total Revenue
12.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Products Offered
12.11.5 Ono Pharmaceutical Co., Ltd Recent Development
12.12 Takeda Pharmaceutical Company Limited
12.12.1 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Corporation Information
12.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Business Overview and Total Revenue
12.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Products Offered
12.12.5 Takeda Pharmaceutical Company Limited Recent Development
12.13 Theravance Biopharma Inc
12.13.1 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Corporation Information
12.13.2 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Business Overview and Total Revenue
12.13.3 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Products Offered
12.13.5 Theravance Biopharma Inc Recent Development
12.14 Bausch Health
12.14.1 Bausch Health Opioid Induced Constipation (OIC) Drugs Corporation Information
12.14.2 Bausch Health Opioid Induced Constipation (OIC) Drugs Business Overview and Total Revenue
12.14.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Bausch Health Opioid Induced Constipation (OIC) Drugs Products Offered
12.14.5 Bausch Health Recent Development
12.15 Cosmo Pharmaceuticals SA
12.15.1 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Corporation Information
12.15.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Business Overview and Total Revenue
12.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Products Offered
12.15.5 Cosmo Pharmaceuticals SA Recent Development
12.16 Daewoong Pharmaceutical
12.16.1 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Corporation Information
12.16.2 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Business Overview and Total Revenue
12.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Products Offered
12.16.5 Daewoong Pharmaceutical Recent Development
12.17 C.B. Fleet Company
12.17.1 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Corporation Information
12.17.2 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Business Overview and Total Revenue
12.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.17.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Products Offered
12.17.5 C.B. Fleet Company Recent Development
12.18 Sucampo Pharmaceuticals
12.18.1 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Corporation Information
12.18.2 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Business Overview and Total Revenue
12.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Products Offered
12.18.5 Sucampo Pharmaceuticals Recent Development

13 Opioid Induced Constipation (OIC) Drugs Manufacturing Cost Analysis
13.1 Opioid Induced Constipation (OIC) Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs
13.4 Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Opioid Induced Constipation (OIC) Drugs Distributors List
14.3 Opioid Induced Constipation (OIC) Drugs Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Opioid Induced Constipation (OIC) Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Region (2015-2020)
Table 5. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Region (2015-2020)
Table 8. Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Opioid Induced Constipation (OIC) Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Opioid Induced Constipation (OIC) Drugs (K Pcs) of Key Companies (2015-2020)
Table 13. Global Opioid Induced Constipation (OIC) Drugs Sales Share by Company (2015-2020)
Table 14. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Company (2015-2020)
Table 16. Global Opioid Induced Constipation (OIC) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Induced Constipation (OIC) Drugs as of 2019)
Table 17. Global Opioid Induced Constipation (OIC) Drugs Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Opioid Induced Constipation (OIC) Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Opioid Induced Constipation (OIC) Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Opioid Induced Constipation (OIC) Drugs Players
Table 22. Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Type (2015-2020)
Table 23. Global Opioid Induced Constipation (OIC) Drugs Sales Share by Type (2015-2020)
Table 24. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Opioid Induced Constipation (OIC) Drugs Price (K Pcs) by Type (2015-2020)
Table 26. Global Opioid Induced Constipation (OIC) Drugs Sales Share by Type (2021-2026)
Table 27. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Type (2021-2026)
Table 29. Global Opioid Induced Constipation (OIC) Drugs Price (K Pcs) by Type (2021-2026)
Table 30. Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Application (2015-2020)
Table 31. Global Opioid Induced Constipation (OIC) Drugs Sales Share by Application (2015-2020)
Table 32. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Opioid Induced Constipation (OIC) Drugs Price (K Pcs) by Application (2015-2020)
Table 34. Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Application (2021-2026)
Table 35. Global Opioid Induced Constipation (OIC) Drugs Sales Share by Application (2021-2026)
Table 36. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Application (2021-2026)
Table 38. Global Opioid Induced Constipation (OIC) Drugs Price (K Pcs) by Application (2021-2026)
Table 39. United States Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Company (2015-2020)
Table 40. United States Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Type (2015-2020)
Table 42. United States Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Application (2015-2020)
Table 44. United States Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2015-2020)
Table 51. China Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Company (2015-2020)
Table 52. China Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company (2015-2020)
Table 53. China Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Type (2015-2020)
Table 54. China Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2015-2020)
Table 55. China Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Application (2015-2020)
Table 56. China Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2015-2020)
Table 69. India Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Company (2015-2020)
Table 70. India Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company (2015-2020)
Table 71. India Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Type (2015-2020)
Table 72. India Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2015-2020)
Table 73. India Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Application (2015-2020)
Table 74. India Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2015-2020)
Table 75. Ironwood Pharmaceuticals Inc Corporation Information
Table 76. Ironwood Pharmaceuticals Inc Description and Business Overview
Table 77. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product
Table 79. Ironwood Pharmaceuticals Inc Recent Development
Table 80. Daiichi Sankyo Co Ltd Corporation Information
Table 81. Daiichi Sankyo Co Ltd Description and Business Overview
Table 82. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product
Table 84. Daiichi Sankyo Co Ltd Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. Pfizer Opioid Induced Constipation (OIC) Drugs Product
Table 89. Pfizer Recent Development
Table 90. Progenics Pharmaceuticals Inc Corporation Information
Table 91. Progenics Pharmaceuticals Inc Description and Business Overview
Table 92. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product
Table 94. Progenics Pharmaceuticals Inc Recent Development
Table 95. Shionogi & Co., Ltd Corporation Information
Table 96. Shionogi & Co., Ltd Description and Business Overview
Table 97. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Product
Table 99. Shionogi & Co., Ltd Recent Development
Table 100. Allergan Plc Corporation Information
Table 101. Allergan Plc Description and Business Overview
Table 102. Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Allergan Plc Opioid Induced Constipation (OIC) Drugs Product
Table 104. Allergan Plc Recent Development
Table 105. Nektar Therapeutics Corporation Information
Table 106. Nektar Therapeutics Description and Business Overview
Table 107. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product
Table 109. Nektar Therapeutics Recent Development
Table 110. Purdue Pharma Corporation Information
Table 111. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Purdue Pharma Description and Business Overview
Table 113. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product
Table 114. Purdue Pharma Recent Development
Table 115. S.L.A. Pharma AG Corporation Information
Table 116. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. S.L.A. Pharma AG Description and Business Overview
Table 118. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product
Table 119. S.L.A. Pharma AG Recent Development
Table 120. Mundipharma International Limited Corporation Information
Table 121. Mundipharma International Limited Description and Business Overview
Table 122. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product
Table 124. Mundipharma International Limited Recent Development
Table 125. Ono Pharmaceutical Co., Ltd Corporation Information
Table 126. Ono Pharmaceutical Co., Ltd Description and Business Overview
Table 127. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product
Table 129. Ono Pharmaceutical Co., Ltd Recent Development
Table 130. Takeda Pharmaceutical Company Limited Corporation Information
Table 131. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 132. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product
Table 134. Takeda Pharmaceutical Company Limited Recent Development
Table 135. Theravance Biopharma Inc Corporation Information
Table 136. Theravance Biopharma Inc Description and Business Overview
Table 137. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 138. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product
Table 139. Theravance Biopharma Inc Recent Development
Table 140. Bausch Health Corporation Information
Table 141. Bausch Health Description and Business Overview
Table 142. Bausch Health Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 143. Bausch Health Opioid Induced Constipation (OIC) Drugs Product
Table 144. Bausch Health Recent Development
Table 145. Cosmo Pharmaceuticals SA Corporation Information
Table 146. Cosmo Pharmaceuticals SA Description and Business Overview
Table 147. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 148. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product
Table 149. Cosmo Pharmaceuticals SA Recent Development
Table 150. Daewoong Pharmaceutical Corporation Information
Table 151. Daewoong Pharmaceutical Description and Business Overview
Table 152. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 153. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product
Table 154. Daewoong Pharmaceutical Recent Development
Table 155. C.B. Fleet Company Corporation Information
Table 156. C.B. Fleet Company Description and Business Overview
Table 157. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 158. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product
Table 159. C.B. Fleet Company Recent Development
Table 160. Sucampo Pharmaceuticals Corporation Information
Table 161. Sucampo Pharmaceuticals Description and Business Overview
Table 162. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 163. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product
Table 164. Sucampo Pharmaceuticals Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Opioid Induced Constipation (OIC) Drugs Distributors List
Table 168. Opioid Induced Constipation (OIC) Drugs Customers List
Table 169. Market Key Trends
Table 170. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 171. Key Challenges
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioid Induced Constipation (OIC) Drugs Product Picture
Figure 2. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Opioid Induced Constipation (OIC) Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies Examples
Figure 7. Retail Pharmacies Examples
Figure 8. Online Pharmacies Examples
Figure 9. Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Opioid Induced Constipation (OIC) Drugs Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Opioid Induced Constipation (OIC) Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Opioid Induced Constipation (OIC) Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Opioid Induced Constipation (OIC) Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Opioid Induced Constipation (OIC) Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Opioid Induced Constipation (OIC) Drugs Players Market Share by Revenue in Opioid Induced Constipation (OIC) Drugs 2015 & 2019
Figure 27. Opioid Induced Constipation (OIC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Type (2015-2020)
Figure 29. Global Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Application (2015-2020)
Figure 31. Global Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type in 2019
Figure 33. United States Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type in 2019
Figure 34. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company in 2019
Figure 35. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type in 2019
Figure 36. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application in 2019
Figure 37. China Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company in 2019
Figure 38. China Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type in 2019
Figure 39. China Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application in 2019
Figure 40. Japan Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company in 2019
Figure 41. Japan Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type in 2019
Figure 42. Japan Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application in 2019
Figure 43. Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company in 2019
Figure 44. Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type in 2019
Figure 45. Southeast Asia Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application in 2019
Figure 46. India Opioid Induced Constipation (OIC) Drugs Sales Market Share by Company in 2019
Figure 47. India Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type in 2019
Figure 48. India Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application in 2019
Figure 49. Ironwood Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Daiichi Sankyo Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Progenics Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Shionogi & Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Allergan Plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Nektar Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Purdue Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. S.L.A. Pharma AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Mundipharma International Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Ono Pharmaceutical Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Takeda Pharmaceutical Company Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Theravance Biopharma Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Cosmo Pharmaceuticals SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Daewoong Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. C.B. Fleet Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Sucampo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Key Raw Materials Price Trend
Figure 68. Manufacturing Cost Structure of Opioid Induced Constipation (OIC) Drugs
Figure 69. Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs
Figure 70. Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Figure 73. Porter's Five Forces Analysis
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

---